Fundraising Fox
Stimdia Medical
Edina, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Stimdia Medical
Sign up to see every warm intro you have to Stimdia Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stimdia Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
Founders & leadership
Stimdia Medical was founded in 2015 by Jay Katarincic and Jim Bullock.
JB
Jim BullockFounder, Stimdia Medical; Board Chairman
PW
Patrick WethingtonExecutivePatrick Wethington is Founder and CEO of PredictiveOne, an AI-focused healthcare venture, and has held leadership and strategic roles across medical device companies including Guidant, Endocardial Solutions, CHF Solutions, CardioInsight, Stimdia Medical, and others, with experience spanning cardiac mapping, heart failure treatment, and neuromodulation technologies.
BS
Brad SwatfagerChief Financial Officer
KL
Kristen LechleiterVice President, Clinical and Regulatory AffairsKristen Lechleiter holds an M.S. in Biomedical Engineering from Washington University in St. Louis and brings over 15 years of life sciences industry experience, including clinical development leadership roles focused on medical device development and clinical research programs.
Investors · 2
Solas BioVentures✓ confirmed by Stimdia MedicalChattanooga
How we know: the company's own site · Solas BioVentures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$21.1M disclosed across 4 of 5 rounds · 2015–2022
- Undisclosed amountSeries A Option 2x FinancingMar 2017Source ↗
▶$16.1MraisedJun 2022 · 14 investors · Other Health CareRule 506(b)
▶$16.1MraisedJun 2022 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jay KatarinicDirector
- James BullockExecutive Officer, Director
- Offering amount
- $30.3M
- Amount sold
- $16.1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedDec 2019 · 7 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BullockExecutive Officer, Director
- Jay KatarinicDirector
- Offering amount
- $3.9M
- Amount sold
- $1.9M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2018 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BullockDirector
- Jay KatarincicDirector
- Patrick WethingtonExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $1.1M
- Minimum investment
- $1
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedDec 2015 · 4 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patrick J WethingtonExecutive Officer, Director
- J.A. Katarincic, Jr.Director
- James BullockDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $1
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
MedidataMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
DiaMedica TherapeuticsDiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. It is a clinical-stage biopharmaceutical company working on treatments for ischemic disorders.
MobiamedicalMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Companies working in the same space as Stimdia Medical.
In the news
Frequently asked questions
- What does Stimdia Medical do?
- Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
- Who founded Stimdia Medical?
- Stimdia Medical was founded by Jay Katarincic, Jim Bullock in 2015.
- Who are Stimdia Medical's investors?
- Stimdia Medical's investors include Solas BioVentures, Fresenius Medical Care Ventures.
- How much funding has Stimdia Medical raised?
- Stimdia Medical has disclosed $21.1M raised across 4 of its 5 known rounds.
- Where is Stimdia Medical headquartered?
- Stimdia Medical is headquartered in Edina, US.